Refractory hemorrhagic esophageal ulcers by Candida esophagitis with advanced systemic sclerosis.
Kazuki NatsuiAtsunori TsuchiyaShuji TeraiPublished in: JGH open : an open access journal of gastroenterology and hepatology (2020)
A 64-year-old woman diagnosed with rheumatoid arthritis (RA) and systemic sclerosis (SSc) was admitted to our hospital with chief complaints of uncontrolled bleeding from esophageal ulcers and an inability to consume meals. For RA and SSc, she was treated with prednisolone and abatacept and was taking vonoprazan as prophylaxis for steroid-induced gastric ulcers. She was diagnosed with severe Candida esophagitis, with multiple large and small ulcers with bleeding, based on esophagogastroduodenoscopy and pathological findings. We performed comprehensive treatment; abatacept was discontinued, and total parenteral nutrition was initiated along with antifungal therapy. Improvement in the esophageal ulcers was observed. Although severe Candida esophagitis is a rare condition, we should keep in mind that severe Candida esophagitis can occur in patients with an immunosuppressive compromised host and esophageal movement disorders such as SSc. Regular follow up by endoscopy and prophylactic treatment to prevent severe esophagitis may be necessary.
Keyphrases
- systemic sclerosis
- rheumatoid arthritis
- interstitial lung disease
- candida albicans
- disease activity
- early onset
- biofilm formation
- drug induced
- healthcare
- wound healing
- ankylosing spondylitis
- helicobacter pylori
- emergency department
- atrial fibrillation
- idiopathic pulmonary fibrosis
- systemic lupus erythematosus
- mesenchymal stem cells
- combination therapy
- pseudomonas aeruginosa
- escherichia coli
- high glucose
- bone marrow
- cystic fibrosis
- staphylococcus aureus
- adverse drug
- replacement therapy